| Structure-aware generation of drug-like molecules | Nov 7, 2021 | Drug Design | —Unverified | 0 | 0 |
| Structure-Based Drug Design via 3D Molecular Generative Pre-training and Sampling | Feb 22, 2024 | Drug DesignMolecular Docking | —Unverified | 0 | 0 |
| Structure-based drug design with geometric deep learning | Oct 19, 2022 | Deep LearningDrug Design | —Unverified | 0 | 0 |
| Surveying the side-chain network approach to protein structure and dynamics: The SARS-CoV-2 spike protein as an illustrative case | Sep 9, 2020 | Drug Design | —Unverified | 0 | 0 |
| SynerGPT: In-Context Learning for Personalized Drug Synergy Prediction and Drug Design | Jun 19, 2023 | Drug DesignIn-Context Learning | —Unverified | 0 | 0 |
| Synthesis-driven design of 3D molecules for structure-based drug discovery using geometric transformers | Dec 31, 2022 | Drug DesignDrug Discovery | —Unverified | 0 | 0 |
| SynthFormer: Equivariant Pharmacophore-based Generation of Synthesizable Molecules for Ligand-Based Drug Design | Oct 3, 2024 | Drug DesignDrug Discovery | —Unverified | 0 | 0 |
| Systems-Structure-Based Drug Design | Oct 14, 2024 | Drug DesignDrug Discovery | —Unverified | 0 | 0 |
| Targets of drugs are generally, and targets of drugs having side effects are specifically good spreaders of human interactome perturbations | May 13, 2015 | Drug Design | —Unverified | 0 | 0 |
| CogMol: Target-Specific and Selective Drug Design for COVID-19 Using Deep Generative Models | Apr 2, 2020 | AttributeDrug Design | —Unverified | 0 | 0 |
| Template-Guided 3D Molecular Pose Generation via Flow Matching and Differentiable Optimization | May 22, 2025 | Drug DesignPose Prediction | —Unverified | 0 | 0 |
| GlycoNMR: Dataset and benchmarks for NMR chemical shift prediction of carbohydrates with graph neural networks | Nov 28, 2023 | Drug Designmolecular representation | —Unverified | 0 | 0 |
| tFold-TR: Combining Deep Learning Enhanced Hybrid Potential Energy for Template-Based Modeling Structure Refinement | May 10, 2021 | Drug DesignProtein Structure Prediction | —Unverified | 0 | 0 |
| The known unknowns of the Hsp90 chaperone | Aug 31, 2023 | Drug DesignKnown Unknowns | —Unverified | 0 | 0 |
| The recent advances in the mathematical modelling of human pluripotent stem cells | Sep 23, 2019 | Drug Design | —Unverified | 0 | 0 |
| The Structural Biology and Critical Evaluation of Bacterial Proteases as Targets in New Drug Design | Jun 3, 2014 | Drug DesignSpecificity | —Unverified | 0 | 0 |
| Token-Mol 1.0: Tokenized drug design with large language model | Jul 10, 2024 | Drug DesignDrug Discovery | —Unverified | 0 | 0 |
| Towards Efficient Molecular Property Optimization with Graph Energy Based Models | Feb 17, 2025 | Drug Design | —Unverified | 0 | 0 |
| Towards Interpretable Sparse Graph Representation Learning with Laplacian Pooling | May 28, 2019 | Drug DesignDrug Discovery | —Unverified | 0 | 0 |
| Hybrid quantum-classical machine learning for generative chemistry and drug design | Aug 26, 2021 | Drug DesignDrug Discovery | —Unverified | 0 | 0 |
| TransDiffSBDD: Causality-Aware Multi-Modal Structure-Based Drug Design | Mar 26, 2025 | Drug DesignDrug Discovery | —Unverified | 0 | 0 |
| Transfer Learning for Bayesian Optimization: A Survey | Feb 12, 2023 | Bayesian OptimizationDrug Design | —Unverified | 0 | 0 |
| Transformative Machine Learning | Nov 8, 2018 | BIG-bench Machine LearningDrug Design | —Unverified | 0 | 0 |
| Two for the Price of One: Integrating Large Language Models to Learn Biophysical Interactions | Mar 26, 2025 | Computational EfficiencyDrug Design | —Unverified | 0 | 0 |
| Understanding of Genetic Code Degeneracy and New Way of Classifying of Protein Family: A Mathematical Approach | Nov 30, 2015 | Drug Design | —Unverified | 0 | 0 |